About: Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 October 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2006 (uk) im Oktober 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 13 October 2006 (en) artículu científicu espublizáu n'ochobre de 2006 (ast)
publication date	wds:Q79236016-4FF9B3EA-5D32-468C-AEDE-C63B0F42B416
publication date	2006-10-13 00:00:00Z (xsd:dateTime)
exact match	wds:Q79236016-7EAD6AD3-36CB-42FC-A058-E8BFACDD1C88
exact match	https://scigraph.springernature.com/pub.10.1007/s10637-006-9012-9
cites work	wds:Q79236016-0FB4F97A-4115-489D-A0EE-83E0E73AA464 wds:Q79236016-15A70C18-BC52-4157-8EE5-CEB3DA3E2D6F wds:Q79236016-17282B93-01B4-4773-A249-7D32CC352794 wds:Q79236016-1D7F92C1-6C67-49C5-ADF9-6B5C9B03ECBD wds:Q79236016-31FCEC19-2E98-48EA-84AB-FDBF560BEA84 wds:Q79236016-6D1062C2-5CA6-4F70-834E-41AF73434F3D wds:Q79236016-88FE7A54-5F3D-4EC0-B06C-8C96B026694A wds:Q79236016-8E5B2677-F2FE-4F88-BC1B-899BCD733D93 wds:Q79236016-936DD82B-E2D8-43D0-A3D2-FCC5CDA8E8AC wds:Q79236016-A10E5F44-41B5-40A1-A08F-F4BCFB7B4B54 wds:Q79236016-A5AD0506-65B4-4D59-968C-5604728A4307 wds:Q79236016-AAD8B1D8-DD49-4AB4-A4CE-0B30E5BA6116 wds:Q79236016-BD3DED57-FDCC-47D2-BE9D-33BC2F6C3660 wds:Q79236016-C47AB3F1-FA65-4E09-9464-49B92D1F6BE8 wds:Q79236016-F4A62BB6-3494-44AD-85DD-8EE6E5BF9371 wds:Q79236016-FC9BECEF-33FA-4D98-9A33-92E04F66D562
cites work	Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: comparative study with doxorubicin. In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite. A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex. Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells. Toxicological aspects of a novel 9-aminoanthracycline, SM-5887. Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients
author name string	wds:Q79236016-049E0E42-F232-4C13-883A-0DD7F1860C0C wds:Q79236016-3726272C-2409-48C0-9E44-4B844B17DBC2 wds:Q79236016-4F7F4321-0A07-41DE-A171-819E7377CBFE wds:Q79236016-645720D7-85B9-480D-8190-D91B5F35877D wds:Q79236016-7F3E6974-A584-43A9-9E12-92A4B38902B3 wds:Q79236016-9CE4996D-B1E9-4200-9B94-B3FF8B7BE75E wds:Q79236016-A46C2A5F-5493-449D-9AA2-AF2E90966DB6 wds:Q79236016-A864805A-190D-4913-A5BC-9F73249B216F wds:Q79236016-AB3B90BB-989E-4CAA-9619-7686D6536A31 wds:Q79236016-C1551D09-A898-4CBB-8675-5A44C25FAEB0 wds:Q79236016-EA684B95-1919-4662-87CC-9E2505690BC1 wds:Q79236016-F2FAEDBB-97D6-4115-AD94-7C061038F31C
author name string	Masaaki Kawahara Masahiro Fukuoka Shunichi Negoro Yoshiki Takada Soichiro Yokota Nobuyuki Katakami Minoru Takada West Japan Thoracic Oncology Group Takahiko Sugiura Yutaka Ariyoshi Hidehiko Yamamoto Takashi Yana
rdfs:label	Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (en) Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (nl)
skos:prefLabel	Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (en) Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (nl)
name	Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (en) Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (nl)
author	wds:Q79236016-BBCD8D3D-2E7C-4FDA-AC3C-20772B7BF61C
author	Toshiyuki Sawa
title	wds:Q79236016-C99A9F5B-D93E-4510-BB2E-4E8FD4C508FA
title	Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study (en)
page(s)	wds:Q79236016-271FF9B6-B8E5-4714-94D1-43DF6AEF416A
page(s)	253-258
instance of	wds:Q79236016-60C64E93-DC95-4D16-8E88-C5CD22351641
instance of	scholarly article
main subject	wds:Q79236016-F9B67118-5C36-47F7-8A0D-63045C6E6268
main subject	lung cancer
PubMed ID	wds:Q79236016-C6858168-98B3-474A-8AB4-077BD6662668
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17039404
PubMed ID	17039404
published in	wds:Q79236016-E982FC29-A41E-4E44-B1E6-8BF318D1F7A8
published in	Investigational New Drugs
issue	wds:Q79236016-AF6EF700-B2EB-414C-A570-A04CDA887648
volume	wds:Q79236016-B799AECC-AE68-446F-A7A9-2EAB3356933E
issue	3
volume	25
DOI	wds:Q79236016-A103632D-0C3A-4785-8B6A-D565BC568F02
DOI	http://dx.doi.org/10.1007/S10637-006-9012-9
DOI	10.1007/S10637-006-9012-9
Dimensions Publication ID	wds:Q79236016-08E8E155-6581-46AA-BB43-5855DCEF01DD
Dimensions Publication ID	1003166376
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79236016
is cites work of	Relapsed small cell lung cancer: treatment options and latest developments Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer Management of small cell lung cancer: recent developments for optimal care

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software